Innovative Drug Delivery Systems, Inc. (IDDS) Releaes: CMO Dan Carr Promoted To Chief Executive Officer
10/19/2005 5:09:25 PM
NEW YORK--(BUSINESS WIRE)--July 6, 2005--Intrac, Inc. (OTC BB: ITRD) and its wholly-owned subsidiary Innovative Drug Delivery Systems (IDDS), a developer of novel pain relief treatments, promoted Daniel B. Carr, M.D. to the position of Chief Executive Officer. In addition to his new duties as CEO, Dr. Carr, will continue to serve as Chief Medical Officer of IDDS, a position he has held since September 2004. Dr, Carr has served on IDDS's Scientific Advisory Board since 2000 and is an internationally recognized expert on pain and its treatment. Dr. Carr has served on advisory boards for Johnson and Johnson, Purdue Pharma, Endo Pharmaceuticals, Abbott Laboratories and a number of other pharmaceutical industry companies. In addition, he has served as a consultant or board member of the American Pain Society, the American Academy of Pain Medicine, the International Association for the Study of Pain, the Legislative Task Force on Pain for the Commonwealth of Massachusetts, the Joint Commission for the Accreditation of Healthcare Organizations and the National Institutes for Health Clinical Center Pain and Palliative Care Working Group.